Chemotherapy-induced hand-foot syndrome (HFS) is a common and distressing side effect experienced by patients undergoing cancer treatment. This condition, also known as palmar-plantar ...
CaboCombo: A prospective international non-interventional study of first-line cabozantinib plus nivolumab for the treatment of patients with advanced renal cell carcinoma. This is an ASCO Meeting ...